Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 161 - 170 of 244 for simcere. (0.12 seconds)

Shanghai Pharma scheduled its upcoming $1.2 billion Hong...
Chongqing Zhifei Biological Products bid $93 million for...
Northeast Pharma of China filed for a $370 million...
Shionogi will pay $185 million to obtain a controlling...
China’s central government spent $38.4 billion on...
The SFDA released a summary of its 2010 decisions,...
China National Biotechnology Group (CNBG) will raise as...
Shanghai Duyiwei Biotechnology, a subsidiary of Gansu...
WuXi AppTec and MedImmune, an AstraZeneca subsidiary,...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here